Michael Egholm - 01 Aug 2025 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Reporting relationship: President & CEO, Director
Issuer ticker: LAB
Reported as of: 01 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Aug 2025, 18:23:22 UTC
Prior SEC filing: 30 May 2025
Next SEC filing: 22 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Michael Egholm by Tomone Tanaka, Attorney-in-Fact

Key filing fact

Michael Egholm filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 05 Aug 2025.

Key facts

This page summarizes Michael Egholm's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Aug 2025, 18:23.

Change

Previous filing in this sequence was filed on 30 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001559779 Primary reporting owner

Egholm Michael

Relationship: President & CEO, Director
Address: C/O STANDARD BIOTOOLS INC., 2 TOWER PLACE, STE 2000, SOUTH SAN FRANCISCO
Signature: /s/ Michael Egholm by Tomone Tanaka, Attorney-in-Fact
Signature date: 05 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LAB transaction

Common Stock

Award

Transaction value: $0
Shares: +3,000,000
Change %: +110%
Price: $0.000000
Shares after: 5,736,285
Date: 01 Aug 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents Restricted Stock Units ("RSUs") that vest as to 25% of the RSUs on August 1, 2026, with the remaining 75% of the RSUs vesting in three equal annual installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.

Footnote F2

Includes 5,000 shares previously acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan.